Tasso is an emerging healthcare company that is transforming the traditional blood collection process with a more convenient and virtually painless approach that focuses on the patient. The company’s OnDemand devices allow people to collect blood with the push of a button from the comfort and privacy of their home, and then mail the samples back to a qualified laboratory for analysis. Headquartered in Seattle, Tasso is privately held and funded by grants from the Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, and the National Institutes of Health, by investments from Hambrecht Ducera Growth Ventures, Merck Global Health Innovation Fund, Foresite Capital, Vertical Venture Partners, Techstars, and Cedars Sinai, and by co-development deals with various industry leaders.

Biotechnology

Tasso

Ben Casavant

Kelsey Burden, MS

Bobby Virasingh

Ann-Li Cooke

Monica Williams

Brett Brennfleck

Levi Ervin

Michael Sheppard

Timothy Bauer

Julien Rohel

John Giammona, PhD

Elizabeth Rosenberg

Duncan Porter

RJ Asplund

Wendy J. Harman

Ryan Asplund

Hal Grubbs

Emily Welch

Clara Behnke

Erwin Berthier

Tasso's Founding Team includes Ben Casavant.

Founding Team

Board of Directors

CEO and Executive Team

Leadership Team

Founding Team

About

Team members

Other teams at Tasso

Board of Directors

CEO and Executive Team

Leadership Team